Advertisement

Age-Related Resistance to Thyroid Hormone Action

  • Arshag D. MooradianEmail author
Review Article
  • 22 Downloads

Abstract

The age-related resistance to thyroid hormones (THs) explains the paucity of symptoms and signs of hyperthyroidism in older adults and may partly explain the myriad of symptoms and signs of hypothyroidism in biochemically euthyroid older people. This review considers the available data on the mechanisms underlying TH resistance with aging and compares these physiologic changes with the changes observed in congenital TH resistance syndromes. Aging is associated with alterations in TH economy along with a host of changes in the responsiveness of various tissues to THs. The age-related resistance to THs can be attributed to decreased TH transport to tissues, decreased nuclear receptor occupancy, decreased activation of thyroxine to triiodothyronine, and alterations in TH responsive gene expression. Although an increase in serum TH levels is expected in syndromes of TH resistance, unchanged serum TH levels in the euthyroid elderly is the result of increased sensitivity to TH negative feedback with increased suppression of thyroid-stimulating hormone, decreased thyroidal sensitivity to thyroid-stimulating hormone, and decreased TH production and secretion. The current clinical evidence suggests that the age-related TH resistance is mostly an adaptive response of the aging organism. It is tempting to speculate that similar changes can occur prematurely in a group of younger people who present with signs and symptoms of hypothyroidism despite normal serum thyroid function tests.

Notes

Compliance with Ethical Standards

Funding

No funding was received for the preparation of this article.

Conflict of interest

Arshag D. Mooradian has no conflicts of interest that are directly relevant to the content of this article.

References

  1. 1.
    Nowak FV, Mooradian AD. Endocrine function and dysfunction. In: Birren JE, editor. Encyclopedia of gerontology: age, aging, and the aged, vol. 1. 2nd ed. San Diego (CA): Elsevier Inc.; 2007. p. 480–93.CrossRefGoogle Scholar
  2. 2.
    Mooradian AD. Biology of aging. In: Felsenthal G, Garrison SJ, Steinberg FU, editors. Rehabilitation of the aging and elderly patient. Baltimore (MD): Williams and Wilkins; 1994. p. 3–10.Google Scholar
  3. 3.
    Oiknine RF, Mooradian AD. Thyroid disorders. In: John Pathy MS, Sinclair AJ, Morley JE, editors. Principles and practice of geriatric medicine, vol. 2. 4th ed. Hoboken: Wiley; 2006. p. 1405–14.Google Scholar
  4. 4.
    Mooradian AD, Wong NCW. Age-related changes in thyroid hormone action. Eur J Endocrinol. 1994;131:451–61.CrossRefGoogle Scholar
  5. 5.
    Mooradian AD. Asymptomatic hyperthyroidism in older adults: is it a distinct clinical and laboratory entity? Drugs Aging. 2008;25:371–80.CrossRefGoogle Scholar
  6. 6.
    Concolino P, Costella A, Paragliola RM. Mutational landscape of resistance to thyroid hormone beta (RTHβ). Mol Diagn Ther. 2019;23:353–68.CrossRefGoogle Scholar
  7. 7.
    Mooradian AD. Normal age-related changes in thyroid hormone economy. Clin Geriatr Med. 1995;11:159–69.CrossRefGoogle Scholar
  8. 8.
    Pekary AE, Mirell CJ, Turner LF Jr, Walfish PG, Hershman JM. Hypothalamic secretion of thyrotropin releasing hormone declines in aging rats. J Endocrinol. 1987;114:271–7.CrossRefGoogle Scholar
  9. 9.
    Lewis GF, Alessi CA, Imperial JG, Refetoff S. Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression. J Clin Endocrinol Metab. 1991;73:843–9.CrossRefGoogle Scholar
  10. 10.
    Friedman D, Reed RL, Mooradian AD. The prevalence of overmedication with levothyroxine in ambulatory elderly patients. Age. 1992;15:9–13.CrossRefGoogle Scholar
  11. 11.
    Suzuki S, Nishio S, Takeda T, Komatsu M. Gender-specific regulation of response to thyroid hormone in aging. Thyroid Res. 2012;5:1.CrossRefGoogle Scholar
  12. 12.
    Tognini S, Polini A, Pasqualetti G, Ursino S, Caraccio N, Ferdeghini M, et al. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study. Thyroid. 2012;22:1096–103.CrossRefGoogle Scholar
  13. 13.
    Ordene KW, Pan C, Barzel US, Surks MI. Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma thyroid hormone concentrations in patients of advanced age. Metabolism. 1983;32:881–8.CrossRefGoogle Scholar
  14. 14.
    Donda A, Lemarchand-Beraud T. Aging alters the activity of 5′-deiodinase in the adenohypophysis, thyroid gland, and liver of the male rat. Endocrinology. 1989;124:1305–9.CrossRefGoogle Scholar
  15. 15.
    Donda A, Reymond MJ, Zurich MG, et al. Influence of sex and age on T3 receptors and T3 concentration in the pituitary gland of the rat: consequences on TSH secretion. Mol Cell Endocrinol. 1987;54:29–34.CrossRefGoogle Scholar
  16. 16.
    Luongo C, Martin C, Vella K, et al. The selective loss of the type 2 iodothyronine deiodinase in mouse thyrotrophs increases basal TSH but blunts the thyrotropin response to hypothyroidism. Endocrinology. 2015;156:745–54.CrossRefGoogle Scholar
  17. 17.
    van Coevorden A, Mockel J, Laurent E, Kerkhofs M, L’Hermite-Balériaux M, Decoster C, et al. Neuroendocrine rhythms and sleep in aging men. Am J Physiol. 1991;260:E651–61.Google Scholar
  18. 18.
    Barreca T, Franceschini R, Messina V, Bottaro L, Rolandi E. 24-Hour thyroid stimulating hormone secretory pattern in elderly men. Gerontology. 1985;31:119–23.CrossRefGoogle Scholar
  19. 19.
    Monzani F, Del Guerra P, Caraccio N, Del Corso L, Casolaro A, Mariotti S, et al. Age-related modifications in the regulation of the hypothalamic-pituitary-thyroid axis. Horm Res. 1996;46:107–12.CrossRefGoogle Scholar
  20. 20.
    Greeley GH Jr, Lipton MA, Kizer JS. Serum thyroxine, triiodothyronine, and TSH levels and TSH release after TRH in aging male and female rats. Endocr Res Commun. 1982–1983;9:169–77.Google Scholar
  21. 21.
    Gregerman RI, Gaffney GW, Shock NW, Crowder SE. Thyroxine turnover in euthyroid man with special reference to changes with age. J Clin Invest. 1962;41:2065–74.CrossRefGoogle Scholar
  22. 22.
    Bano A, Chaker L, Schoufour J, et al. High circulating free thyroxine levels may increase the risk of frailty: the Rotterdam Study. J Clin Endocrinol Metab. 2018;103:328–35.CrossRefGoogle Scholar
  23. 23.
    van den Beld AW, Visser TJ, Feelders RA, Grobbee DE, Lamberts SWJ. Thyroid hormone concentration, disease, physical function and mortality in elderly men. J Clin Endocrinol Metab. 2005;90:6403–9.CrossRefGoogle Scholar
  24. 24.
    van Coevorden A, Laurent E, Decoster C, Kerkhofs M, Neve P, van Cauter E, et al. Decreased basal and stimulated thyrotropin secretion in healthy elderly men. J Clin Endocrinol Metab. 1989;69:177–85.CrossRefGoogle Scholar
  25. 25.
    Mariotti S, Barbesino G, Caturegli P, Bartalena L, Sansoni P, Fagnoni F, et al. Complex alteration of thyroid function in healthy centenarians. J Clin Endocrinol Metab. 1993;77:1130–4.Google Scholar
  26. 26.
    Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab. 2007;92:4575–82.CrossRefGoogle Scholar
  27. 27.
    Surks MI, Boucai L. Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab. 2010;95:496–502.CrossRefGoogle Scholar
  28. 28.
    Atzmon G, Barzilai N, Hollowell JG, Surks MI, Gabriely I. Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab. 2009;94:1251–4.CrossRefGoogle Scholar
  29. 29.
    Mooradian AD. Subclinical hypothyroidism in the elderly: to treat or not to treat? Am J Ther. 2011;18:477–86.CrossRefGoogle Scholar
  30. 30.
    Peeters RP, Visser TJ. Metabolism of thyroid hormone. Endotext [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK285545/. Accessed 1 Sep 2019.
  31. 31.
    Pasqualetti G, Calsolaro V, Bernardini S, Linsalata G, Bigazzi R, Caraccio N, et al. Degree of peripheral thyroxin deiodination, frailty, and long-term survival in hospitalized older patients. J Clin Endocrinol Metab. 2018;103:1867–76.CrossRefGoogle Scholar
  32. 32.
    Mooradian AD, Lieberman J. Age-related decrease in serum angiotensin converting enzyme activity: the role of thyroidal status and food intake. J Gerontol Biol Sci. 1990;45:B24–7.CrossRefGoogle Scholar
  33. 33.
    Gambert SR. Effect of age on basal and 3,5,3′ triiodothyronine (T3) stimulated human mononuclear cell sodium-potassium adenosine-triphosphatase (Na+–K+ ATP’ase) activity. Horm Metab Res. 1986;18:649–50.CrossRefGoogle Scholar
  34. 34.
    Davis PJ, Davis FB, Blas SD, Schoenl M, Edwards L. Donor age-dependent decline in response of human red cell Ca2+-ATPase activity to thyroid hormone in vitro. J Clin Endocrinol Metab. 1987;64:921–5.CrossRefGoogle Scholar
  35. 35.
    Davis FB, Deziel MR, Van Liew JB, et al. Effects of caloric restriction and aging on erythrocyte membrane Ca2+-ATPase activity in specific pathogen free Fischer 344 rats. Metabolism. 1991;40:819–24.CrossRefGoogle Scholar
  36. 36.
    Segal J, Troen BR. Effect of age on the 3,5,3′-tri-iodothyronine-induced increase in sugar uptake in rat thymocytes. J Endocrinol. 1986;110:511–5.CrossRefGoogle Scholar
  37. 37.
    Gambert SR, Ingbar SH, Hagen EC. Interaction of age and thyroid hormone status on Na+–K+–ATPase in rat renal cortex and liver. Endocrinology. 1981;108:27–30.CrossRefGoogle Scholar
  38. 38.
    Chehade J, Kim J, Pinnas JL, Mooradian AD. Age-related changes in the thyroid hormone effects on malondialdehyde modified proteins in the rat heart. Proc Soc Exp Biol Med. 1999;222:59–64.Google Scholar
  39. 39.
    Mooradian AD, Deebaj L, Wong NCW. Age-related alterations in the response of hepatic lipogenic enzymes to altered thyroid states in the rat. J Endocrinol. 1991;128:79–84.CrossRefGoogle Scholar
  40. 40.
    Mooradian AD, Albert SG. The age-related changes in lipogenic enzymes: the role of dietary factors and thyroid hormone responsiveness. Mech Age Develop. 1999;108:139–49.CrossRefGoogle Scholar
  41. 41.
    Mooradian AD, Wong NCW, Shah GN. Age-related changes in the responsiveness of apolipoprotein A1 to thyroid hormone. Am J Physiol. 1996;271:R1602–7.Google Scholar
  42. 42.
    Mooradian AD, Fox-Robichaud A, Meijer ME, Wong NCW. Relationship between transcription factors and S14 gene expression in response to thyroid hormone and age. Proc Soc Exp Biol Med. 1994;207:97–101.CrossRefGoogle Scholar
  43. 43.
    Maciel LM, Polikar R, Rohrer D, Popovich BK, Dillmann WH. Age-induced decreases in the messenger RNA coding for the sarcoplasmic reticulum Ca2(+)-ATPase of the rat heart. Circ Res. 1990;67:230–4.CrossRefGoogle Scholar
  44. 44.
    Effron MB, Bhatnager GM, Spurgeon HA, Ruano-Arroyo G, Lakatta EG. Changes in myosin isoenzymes, ATPase activity and contraction duration in rat cardiac muscle with aging can be modulated by thyroxine. Circ Res. 1987;60:238–45.CrossRefGoogle Scholar
  45. 45.
    O’Neil L, Holbrook N, Lakatta EG. Progressive changes from young adult age to senescence in mRNA for rat cardiac myosin heavy chain. Cardioscience. 1992;2:1–5.Google Scholar
  46. 46.
    Mooradian AD, Chehade J, Kim J. Age-related changes in thyroid hormone effects on glucose transporter isoforms of rat heart. Life Sci. 1999;65:981–9.CrossRefGoogle Scholar
  47. 47.
    Mooradian AD, Scarpace PJ. The response of isoproterenol-stimulated adenylate cyclase activity after administration of l-triiodothyronine is reduced in aged rats. Horm Metab Res. 1989;21:638–9.CrossRefGoogle Scholar
  48. 48.
    Scarpace PJ, Abrass IB. Thyroid hormone regulation of beta-adrenergic receptor number in aging rats. Endocrinology. 1981;108:1276–8.CrossRefGoogle Scholar
  49. 49.
    Gresik EW, Wenk-Salamone K, Onetti-Muda A, Gubits RM, Shaw PA. Effect of advanced age on the induction by androgen or thyroid hormone of epidermal growth factor and epidermal growth factor mRNA in the submandibular glands of C57BL/6 male mice. Mech Ageing Dev. 1986;34:175–89.CrossRefGoogle Scholar
  50. 50.
    Gresik EW, Maruyama S. Inductive effects of triiodothyronine or dihydrotestosterone on EGF in the submandibular glands of young, middle-aged, and old C57BL/6NNia female mice. J Gerontol. 1987;42:491–6.CrossRefGoogle Scholar
  51. 51.
    Haas MJ, Mreyoud A, Fishman M, Mooradian AD. Microarray analysis of thyroid hormone-induced changes in mRNA expression in the adult rat brain. Neurosci Lett. 2004;365:14–8.CrossRefGoogle Scholar
  52. 52.
    Mooradian AD, Scarpace PJ. β-Adrenergic receptor activity of cerebral microvessels is reduced in aged rats. Neurochem Res. 1991;16:447–51.CrossRefGoogle Scholar
  53. 53.
    Mooradian AD, Scarpace PJ. 3,5,3′-l-triiodothyronine regulation of B-adrenergic receptor density and adenylyl cyclase activity in synaptosomal membranes of aged rats. Neurosci Lett. 1993;161:101–4.CrossRefGoogle Scholar
  54. 54.
    Mooradian AD, Girgis WE, Shah GN. Thyroid hormone-induced GLUT-1 expression in rat cerebral tissue: effect of age. Brain Res. 1997;747:144–6.CrossRefGoogle Scholar
  55. 55.
    Shah GN, Li J, Mooradian AD. Novel translational repressor (NAT-1) expression is modified by thyroid state and age in brain and liver. Eur J Endocrinol. 1999;139:649–53.CrossRefGoogle Scholar
  56. 56.
    Mooradian AD, Li J, Shah GN. Age-related changes in thyroid hormone responsiveness protein (THRP) expression in cerebral tissue of rats. Brain Res. 1998;793:302–4.CrossRefGoogle Scholar
  57. 57.
    Mooradian AD, Habib MP, Dickerson F, Yetskievych T. The effect of age on l-3,5,3′, triiodothyronine induced ethane exhalation. J Appl Physiol. 1994;77:160–4.CrossRefGoogle Scholar
  58. 58.
    Mooradian AD. Age-related differences in body weight loss in response to altered thyroidal status. Exp Gerontol. 1990;25:29–35.CrossRefGoogle Scholar
  59. 59.
    Mooradian AD. The hepatic transcellular transport of 3,5,3′-triiodothyronine is reduced in aged rats. Biochim Biophys Acta. 1990;1054:1–7.CrossRefGoogle Scholar
  60. 60.
    Mooradian AD. Blood–brain transport of triiodothyronine is reduced in aged rats. Mech Ageing Dev. 1990;52:141–7.CrossRefGoogle Scholar
  61. 61.
    Kvetny J. Nuclear thyroxine and triiodothronine binding in mononuclear cells in dependence of age. Horm Metab Res. 1985;17:35–8.CrossRefGoogle Scholar
  62. 62.
    Jang M, DiStefano JJ 3rd. Some quantitative changes in iodothyronine distribution and metabolism in mild obesity and aging. Endocrinology. 1985;116:457–68.CrossRefGoogle Scholar
  63. 63.
    Visser WE, Bombardieri CR, Zevenbergen C, et al. Tissue-specific suppression of thyroid hormone signaling in various mouse models of aging. PLoS One. 2016;11(3):e0149941.CrossRefGoogle Scholar
  64. 64.
    Onigata K, Szinnai G. Resistance to thyroid hormone. Endocr Dev. 2014;26:118–29.CrossRefGoogle Scholar
  65. 65.
    Ochs N, Auer R, Bauer DC, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008;148:832–45.CrossRefGoogle Scholar
  66. 66.
    Forti P, Olivelli V, Rietti E, Maltoni B, Pirazzoli G, Gatti R, et al. Serum thyroid-stimulating hormone as a predictor of cognitive impairment in an elderly cohort. Gerontology. 2012;58:41–9.CrossRefGoogle Scholar
  67. 67.
    Winkler A, Weimar C, Jöckel KH, Erbel R, Dragano N, Broecker-Preuss M, et al. Thyroid-stimulating hormone and mild cognitive impairment: results of the Heinz Nixdorf recall study. J Alzheimers Dis. 2016;49:797–807.CrossRefGoogle Scholar
  68. 68.
    Chaker L, Baumgartner C, den Elzen WP, et al. Subclinical hypothyroidism and the risk of stroke events and fatal stroke: an individual participant data analysis. J Clin Endocrinol Metab. 2015;100:2181–91.CrossRefGoogle Scholar
  69. 69.
    Razvi S, Shakoor A, Vanderpump M, et al. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab. 2008;93:2998–3007.CrossRefGoogle Scholar
  70. 70.
    Pasqualetti G, Pagano G, Rengo G, Ferrara N, Monzani F. Subclinical hypothyroidism and cognitive impairment: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100:4240–8.CrossRefGoogle Scholar
  71. 71.
    Ojala AK, Schalin-Jäntti C, Pitkälä KH, Tilvis RS, Strandberg TE. Serum thyroid-stimulating hormone and cognition in older people. Age Ageing. 2016;45:155–7.CrossRefGoogle Scholar
  72. 72.
    Gussekloo J, van Exel E, de Craen AJ, et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292:2591–9.CrossRefGoogle Scholar
  73. 73.
    Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295:1033–41.CrossRefGoogle Scholar
  74. 74.
    Chueire VB, Romaldini JH, Ward LS. Subclinical hypothyroidism increases the risk for depression in the elderly. Arch Gerontol Geriatr. 2007;44:21–8.CrossRefGoogle Scholar
  75. 75.
    Mariotti S. Thyroid function and aging: do serum 3,5,3′-triiodothyronine and thyroid-stimulating hormone concentrations give the Janus response? J Clin Endocrinol Metab. 2005;90:6735–7.CrossRefGoogle Scholar
  76. 76.
    Mobbs CV, Bray GA, Atkinson RL, et al. Neuroendocrine and pharmacological manipulations to assess how caloric restriction increases life span. J Gerontol. 2001;56A:34–44.CrossRefGoogle Scholar
  77. 77.
    Blanc S, Schoeller D, Kemnitz J, et al. Energy expenditure of rhesus monkeys subjected to 11 years of dietary restriction. J Clin Endocrinol Metab. 2003;88:16–23.CrossRefGoogle Scholar
  78. 78.
    Ooka H, Shinkai T. Effects of chronic hyperthyroidism on the lifespan of the rat. Mech Ageing Dev. 1986;33:275–82.CrossRefGoogle Scholar
  79. 79.
    Speakman JR, Selman C, McLaren JS, et al. Living fast, dying when? The link between aging and energetics. J Nutr. 2002;132(Suppl. 2):S1538–97.Google Scholar
  80. 80.
    Rieben C, Segna D, da Costa BR, et al. Subclinical thyroid dysfunction and the risk of cognitive decline: a meta-analysis of prospective cohort studies. J Clin Endocrinol Metab. 2016;101:4945–54.CrossRefGoogle Scholar
  81. 81.
    Aubert CE, Bauer DC, da Costa BR, et al. The association between subclinical thyroid dysfunction and dementia: the Health, Aging and Body Composition (Health ABC) Study. Clin Endocrinol (Oxf). 2017;87:617–26.CrossRefGoogle Scholar
  82. 82.
    Gan EH, Pearce SH. Clinical review: the thyroid in mind: cognitive function and low thyrotropin in older people. J Clin Endocrinol Metab. 2012;97:3438–49.CrossRefGoogle Scholar
  83. 83.
    Annerbo S, Lökk J. A clinical review of the association of thyroid stimulating hormone and cognitive impairment. ISRN Endocrinol. 2013;2013:856017.CrossRefGoogle Scholar
  84. 84.
    Moon JH, Park YJ, Kim TH, et al. Lower-but-normal serum TSH level is associated with the development or progression of cognitive impairment in elderly: Korean Longitudinal Study on Health and Aging (KLoSHA). J Clin Endocrinol Metab. 2014;99:424–32.CrossRefGoogle Scholar
  85. 85.
    Delitala AP. Subclinical hyperthyroidism and the cardiovascular disease. Horm Metab Res. 2017;49:723–31.CrossRefGoogle Scholar
  86. 86.
    Williams GR, Bassett JHD. Thyroid diseases and bone health. J Endocrinol Invest. 2018;41:99–109.CrossRefGoogle Scholar
  87. 87.
    Ostan R, Monti D, Mari D, et al. Heterogeneity of thyroid function and impact of peripheral thyroxine deiodination in centenarians and semi-supercentenarians: association with functional status and mortality. J Gerontol A Biol Sci Med Sci. 2019;16(74):802–10.CrossRefGoogle Scholar
  88. 88.
    Stott DJ, Rodondi N, Kearney PM, et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med. 2017;376:2534–44.CrossRefGoogle Scholar
  89. 89.
    Franceschi C, Ostan R, Mariotti S, Monti D, Vitale G. The aging thyroid: a reappraisal within the geroscience integrated perspective. Endocr Rev. 2019;40:1250–70.Google Scholar
  90. 90.
    Piehl S, Hoefig CS, Scanlan TS, Köhrle J. Thyronamines: past, present, and future. Endocr Rev. 2011;32:64–80.CrossRefGoogle Scholar
  91. 91.
    Groeneweg S, Peeters RP, Visser TJ, Visser WE. Therapeutic applications of thyroid hormone analogues in resistance to thyroid hormone (RTH) syndromes. Mol Cell Endocrinol. 2017;458:82–90.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of MedicineUniversity of Florida College of MedicineJacksonvilleUSA

Personalised recommendations